Nano Labs Ltd (NA)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 50M 100M 150M FY22: 141.2M FY23: 11.1M FY24: 5.6M FY25: 3.8M FY22 FY23 FY24 FY25

Gross Profit Annual

-15M 0 15M 30M 45M FY22: 33M FY23: -14.6M FY24: 1.6M FY25: -5.7M FY22 FY23 FY24 FY25

Operating Income Annual

-45M -30M -15M 0 15M 30M 45M FY22: 3M FY23: -36.8M FY24: -13.7M FY25: 10.2M FY22 FY23 FY24 FY25

Net Income Annual

-45M -30M -15M 0 15M 30M 45M FY22: 4.5M FY23: -35.7M FY24: -15.7M FY25: 19.3M FY22 FY23 FY24 FY25

Cost of Revenue Annual

0 40M 80M 120M FY22: 108.1M FY23: 25.7M FY24: 4M FY25: 9.5M FY22 FY23 FY24 FY25

Operating Cash Flow Annual

-45M -30M -15M 0 15M 30M 45M FY22: -39.5M FY23: -18.8M FY24: -19.4M FY25: -15.4M FY22 FY23 FY24 FY25

Free Cash Flow Annual

-45M -30M -15M 0 15M 30M 45M FY22: -42M FY23: -33.7M FY24: -24.4M FY25: -15.4M FY22 FY23 FY24 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 30M 60M 90M FY20: 79.2M FY21: 44.9M FY22: 5.3M FY23: 5.9M FY24: 8M FY25: 19.9M FY20 FY21 FY22 FY23 FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.